Indian subsidiary of Colgate-Palmolive; makes Colgate oral-care and Palmolive personal-care products.
Price
Market Cap
Sector
Fast Moving Consumer Goods
Rank
| Line item | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 | FY26 |
|---|---|---|---|---|---|---|---|---|
| LiabilitiesEquity Capital | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 27 |
| Reserves | 1.6k | 1.1k | 1.7k | 1.7k | 1.8k | 1.6k | 1.6k | 1.6k |
| Borrowings | 102 | 91 | 83 | 69 | 72 | 61 | 60 | 47 |
| Other Liabilities | 908 | 1.6k | 1.1k | 1.1k | 1.3k | 1.3k | 1.5k | 1.8k |
| Total Liabilities | 2.6k | 2.9k | 2.9k | 2.9k | 3.2k | 3.0k | 3.2k | 3.4k |
| AssetsFixed Assets | 1.1k | 1.1k | 963 | 862 | 794 | 776 | 742 | 718 |
| CWIP | 190 | 145 | 122 | 114 | 110 | 38 | 29 | 27 |
| Investments | 19 | 19 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 1.3k | 1.7k | 1.8k | 1.9k | 2.3k | 2.2k | 2.4k | 2.7k |
| Total Assets | 2.6k | 2.9k | 2.9k | 2.9k | 3.2k | 3.0k | 3.2k | 3.4k |
| Line item | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|
| ActivitiesCash from Operating | 983 | 930 | 784 | 1.6k | 1.2k | 1.2k | 1.4k | 1.8k |
| Cash from Investing | -96 | -19 | 71 | -108 | -8 | 79 | 56 | 374 |
| Cash from Financing | -815 | -891 | -956 | -1.1k | -1.1k | -1.2k | -1.7k | -1.4k |
| SummaryCapital Expenditure | — | — | — | — | — | — | — | — |
| Free Cash Flow | 879 | 869 | 727 | 1.6k | 1.1k | 1.1k | 1.3k | 1.7k |
| FCF Margin | — | — | — | — | — | — | — | — |
The Earnings Per Share over the last 12 months.
Your assumption of the company's expected yearly EPS growth (e.g., 6 for 6%).
Pre-filled with the lower of median (47.1×) and current (41.0×) PE — the conservative anchor.
The annualized return you aim to achieve. We solve for the price that delivers it, then compare to today's price.
At 8.2% growth and a 41× exit, ₹1998 only delivers your return if you pay ₹1,265. The price is currently baking in 18% growth.
EPS grows 8.2%/yr for 5 years, then fades to 6% over 2, exits at 41×.
| Year | Growth | EPS (₹) |
|---|---|---|
| FY27 | 8.2% | 52.73 |
| FY28 | 8.2% | 57.05 |
| FY29 | 8.2% | 61.73 |
| FY30 | 8.2% | 66.79 |
| FY31 | 8.2% | 72.27 |
| FY32 | 7.1% ·fade | 77.40 |
| FY33 | 6.0% ·fade | 82.04 |
Methodology: we discount normalized net profit as a proxy for owner earnings (an earnings-power approximation — not full free cash flow). Terminal growth is capped at 6% (≈ nominal GDP) regardless of the required return. This is an analytical tool, not investment advice.
Guides on how to read this kind of business and the numbers that matter.